PlexusDx evaluates each patient through a comprehensive health intake that considers fasting glucose, insulin levels, lipid panels, and personal metabolic risk factors
During your consultation, we will determine whether or not our weight loss program is right for you
Patients should inform their procedural and anesthesia teams if they take GLP-1 or dual incretin therapy, including Ozempic, Wegovy, Rybelsus, Trulicity, Victoza, Saxenda, Mounjaro, or Zepbound
If symptoms, lab concerns, or a known medical condition are driving the question, a clinician should help determine whether testing, primary care follow-up, or another next step is needed
Pfizer, Amgen, and dozens of smaller biotechs are racing to develop GLP-1 alternatives
EMSCULPT NEO FAQs Who is more suitable for an EMSculpt Neo treatment